Alternative Splicing Determines The Carboxy Terminus of the Epstein—Barr Virus Nuclear Antigen 5 Species Expressed in the Burkitt's Lymphoma Cell Line Daudi

References

1. Allan G., Rowe D. T. 1989; Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt’s lymphoma and lymphoblastoid cell lines. Virology 173:489–498
   [Google Scholar]
2. Allan G. J., Inman G. J., Parker B. D., Rowe D. T., Farrell P. J. 1992; Cell growth effects of Epstein-Barr virus leader protein. Journal of General Virology 73:1547–1551
   [Google Scholar]
3. Dillner J., Kallin B., Alexander H., Ernberg I., Uno M., Ono Y., Klein G., Lerner R. A. 1986; An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoid cell lines. Proceedings of the National Academy of Sciences, U.S.A. 83:6641–6645
   [Google Scholar]
4. Dyson N., Howley P. M., Münger K., Harlow E. 1989; The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937
   [Google Scholar]
5. Favaloro J., Treisman R., Kamen R. 1980; Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. Methods in Enzymology 65:718–749
   [Google Scholar]
6. Finke J., Rowe M., Kallin B., Ernberg I., Rosen A., Dillner J., Klein G. 1987; Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA5) detect multiple protein species in Burkitt’s lymphoma and lymphoblastoid cell lines. Journal of Virology 61:3870–3878
   [Google Scholar]
7. Gregory C. D., Rowe M., Rickinson A. B. 1990; Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt’s lymphoma cell line. Journal of General Virology 71:1481–1495
   [Google Scholar]
8. Hammerschmidt W., Sugden B. 1989; Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature, London 340:393–397
   [Google Scholar]
9. Jeang K.-T., Hayward S. D. 1983; Organisation of the Epstein-Barr virus DNA molecule III. Location of the P3HR-1 deletion junction and characterization of the Notl repeat units that form part of a template for an abundant TPA induced RNA transcript. Journal of Virology 48:135–148
   [Google Scholar]
10. Jenson H. B., Farrell P. J., Miller G. 1987; Sequences of the Epstein-Barr virus (EBV) large internal repeat form the centre of a 16-kilobase pair palindrome of EBV (P3HR-1) heterogeneous DNA. Journal of Virology 61:1495–1506
    [Google Scholar]
11. Jiang W.-Q., Szekely L., Wendel-Hansen V., Ringertz N., Klein G., Rosen A. 1991; Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Experimental Cell Research 197:314–318
    [Google Scholar]
12. Jones M. D., Foster L., Sheedy T., Griffin B. E. 1984; The EB virus genome in Daudi Burkitt’s lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO Journal 3:813–821
    [Google Scholar]
13. Kawasaki E. S. 1990; Amplification of RNA. In PCR Protocols: A Guide to Methods and Applications pp. 21–27 Edited by Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. San Diego: Academic Press;
    [Google Scholar]
14. Mannick J. B., Cohen J. I., Birkenbach M., Marchini A., Kieff E. 1991; The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. Journal of Virology 65:6826–6837
    [Google Scholar]
15. Rogers R. P., Woisetschlaeger M., Speck S. H. 1990; Alternative splicing dictates translational start in Epstein-Barr virus transcripts. EMBO Journal 9:2273–2277
    [Google Scholar]
16. Rooney C., Howe J. G., Speck S. H., Miller G. 1988; Influence of Burkitt’s lymphoma and primary B cells on latent gene expression by a non-immortalizing strain of Epstein-Barr virus. Journal of Virology 63:1531–1539
    [Google Scholar]
17. Rowe D. T., Farrell P. J., Miller G. 1987; Novel nuclear antigen recognized by human sera in lymphocytes latently infected by Epstein-Barr virus. Virology 156:153–162
    [Google Scholar]
18. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
19. Sample J., Hummel M., Braun D., Birkenbach M., Kieff E. 1986; Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable translational initiation site. Proceedings of the National Academy of Sciences, U.S.A. 83:5096–5100
    [Google Scholar]
20. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A. 74:5463–5467
    [Google Scholar]
21. Speck S. H., Strominger J. L. 1989; Transcription of Epstein-Barr virus in latently infected, growth transformed lymph-cytes. Advances in Viral Oncology 8:133–150
    [Google Scholar]
22. Speck S. H., Pfitzner A., Strominger J. L. 1986; An Epstein-Barr virus transcript from a latently infected, growth transformed B-cell line encodes a highly repetitive polypeptide. Proceedings of the National Academy of Sciences, U.S.A. 83:9298–9302
    [Google Scholar]
23. Wang F., Petti L., Braun D., Seung S., Kieff E. 1987; A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth transformed lymphocytes. Journal of Virology 61:945–954
    [Google Scholar]